Paratek Pharmaceuticals, Inc.
(NASDAQ GM: PRTK)
Rigrodsky Law, P.A. is investigating Paratek Pharmaceuticals, Inc. (“Paratek”) regarding possible breaches of fiduciary duties and other violations of law related to Paratek’s agreement to be acquired by Gurnet Point Capital and Novo Holdings.